Saturday, May 21, 2022
No Result
View All Result
Medical Finance
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
No Result
View All Result
Medical Finance
No Result
View All Result
Home Coronavirus

Impact of humoral responses in COVID-19

by Medical Finance
in Coronavirus
Study: Protective and pathogenic role of humoral responses in COVID-19. Image Credit: CROCOTHERY/Shutterstock
9
SHARES
99
VIEWS
Share on FacebookShare on Twitter

A recent study published in the Journal of Microbiology discussed the function and impact of humoral immune responses in coronavirus disease 2019 (COVID-19).

Study: Protective and pathogenic role of humoral responses in COVID-19. Image Credit: CROCOTHERY/Shutterstock
Study: Protective and pathogenic role of humoral responses in COVID-19. Image Credit: CROCOTHERY/Shutterstock

Globally, there have been over 440 million confirmed cases of COVID-19, including 5.9 million deaths to date. A majority of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections are either asymptomatic or present mild symptoms, though, less than 20% of the patients do suffer from acute respiratory syndrome (ARDS) or severe pneumonia. Despite the collective global effort, the viral mechanisms causing these COVID-19 complications are still unclear.

Differential antibody responses related to COVID-19 severity

Acute viral infections are generally characterized by higher viral loads and ineffective viral clearance which are associated with severe disease outcomes. However, studies have reported that the levels of SARS-CoV-2 viral loads are not associated with the severity of COVID-19. Also, slower viral clearance has been found in patients younger than 60 years exhibiting more severe disease manifestations and in patients above 60 years irrespective of their disease severity.

Patients with overt inflammation or dysregulated immune responses are at a higher risk of disease progression. Also, clinical parameters were correlated with the presence of higher amounts of virus-specific antibodies. Additionally, patients with severe manifestations of COVID-19 had more robust and quicker antibody responses as compared to patients with mild disease progression. Overall, a positive association between the survival of SARS-COV-2-infected patients and their antibody levels has been widely reported.

A study conducted by Secchi et al. reported the presence of a specific immunoglobulin G (IgG) in the SARS-CoV-2 receptor-binding domain (RBD) as a predictor of survival in SARS-CoV-2 patients. On the other hand, Garcia-Beltran et al. reported that survival could be indicated by a higher neutralization potency of antibodies while Lucas et al. found that the production of neutralizing antibodies within 14 days of symptom onset could guarantee patient recovery. It was also reported that patients with severe disease produced a larger amount of neutralizing antibodies at a higher speed as compared to non-critical or asymptomatic patients.    

Differential B cell immunity predicted severity of COVID-19

One study showed that patients with severe COVID-19 showed characteristics of extrafollicular B cell activation and associated B cell manifestations. This extrafollicular activation is strongly associated with an expansion of cells secreting antibodies, thus explaining the high amounts of SARS-CoV-2-specific neutralizing antibodies in the early stages of infection. The generation of high concentrations of antibodies could also be due to the responses of viral antigen-specific B cells which in turn are caused by T-helper 2 (TH2)-skewed immunity.

The delayed viral antigen clearance was reported to cause antigen-specific germinal center (GC) reactions in lymphoid organs. Also, asymptomatic subjects had lymphopenia, a lower number of antibody-secreting cells, a lower number of B-cells, as well as a low cytokine response. In contrast, the number of total memory B cells was found to be significantly lower in patients with severe COVID-19. This B cell reduction then led to dysregulated humoral immune responses. Altogether, these studies highlighted the dysregulation of B cell responses based on COVID-19 severity, which could be one of the major reasons for COVID-19 disease progression.

Pathogenic impact of COVID-19 antibody responses

Dysregulated antibody responses in COVID-19 patients can manifest as worsened cytokine storms, vasculopathy, coagulopathy, and thrombosis. The presence of IgG-positive immune complexes deposited in the lungs of six fatal cases indicated that this complex is associated with ARDS-related symptoms in fatal cases. Studies have also reported that cytokine storms induced by the enhanced inflammatory immune complex cause the production of proinflammatory cytokines, worsening the pathogenesis of COVID-19.

The reduced viral release from COVID-19-infected cells in patients facilitated the binding of the antibodies produced with viral antigens and indicated that pulmonary cells are primary targets for the antigen-antibody immune complexes in COVID-19 patients. Also, the reduced tolerance of B cells impacted by prolonged activation of extrafollicular B cells could lead to autoreactive antibody responses, which in turn could further worsen COVID-19 pathogenesis. COVID-19 patients had high quantities of autoantibodies against immunomodulatory proteins, disturbing the immune function by lowering immunoreceptor signaling.

Antibody responses and the selection of antibody-escaping variants

Studies have reported the importance of mutations conserved in the SARS-CoV-2 spike protein in increasing COVID-19 transmission and/or binding affinity to the angiotensin-converting enzyme 2 (ACE2) receptor along with the reduced susceptibility of the protein to preexisting neutralizing antibodies.

SARS-CoV-2 variants like Kappa and variants of concern (VOCs) such as Delta showed increased infectivity and higher resistance to neutralizing antibodies as compared to the SARS-CoV2 D614G mutant. In comparison, the Omicron VOC had lower neutralizing sensitivity to the immune sera of vaccinated or convalescent individuals.

Based on these observations, the researchers concluded that the dysregulation of humoral responses in COVID-19 and the accompanying inflammatory reactions could be targeted for the development of future anti-COVID-19 therapeutics.

Total
0
Shares
Share 0
Tweet 0
Pin it 0
Share 0
Medical Finance

Medical Finance

Related Posts

Study: A unique dexamethasone-dependent gene expression profile in the lungs of COVID-19 patients. Image Credit: Alexandros Michailidis/Shutterstock

Dexamethasone shown to upregulate innate and adaptive immune responses in COVID-19 acute respiratory distress syndrome patients

by Medical Finance
May 20, 2022
0

In a recent cross-sectional study posted to the medRxiv* preprint server, researchers used per protocol bronchoalveolar lavage fluid (BALF) samples...

Study: The Conserved Macrodomain Is a Potential Therapeutic Target for Coronaviruses and Alphaviruses. Image Credit: Design_Cells / Shutterstock

Macrodomains represent a unique target for pathogens with pandemic potential

by Medical Finance
May 20, 2022
0

Scientists have long stated that the emergence and re-emergence of infectious viral diseases, such as severe acute respiratory syndrome coronavirus...

Study: Green tea consumption and SARS-CoV-2 infection among staff of a referral hospital in Japan. Image Credit: grafvision/Shutterstock

The association between green tea consumption and SARS-CoV-2 infection among Japanese

by Medical Finance
May 20, 2022
0

A study recently published in the Clinical Nutrition Open Science journal examined the association between consumption of green tea...

Officials struggle to regulate pop-up covid testing sites — and warn patients to beware

Roe v. Wade’s (possibly last) anniversary

by Medical Finance
May 20, 2022
0

Jan. 22 is the 49th anniversary of the Supreme Court's landmark abortion ruling, Roe v. Wade, and could well be...

Study: Testing behaviour may bias observational studies of vaccine effectiveness. Image Credit: Tong_stocker/Shutterstock

Impact of SARS-CoV-2 testing behavior on observational studies of vaccine efficiency

by Medical Finance
May 20, 2022
0

In a recent study posted to the medRxiv* pre-print server, a team of researchers performed an observational study to understand...

Study: Continued Emergence and Evolution of Omicron in South Africa: New BA.4 and BA.5 lineages. Image Credit: Viacheslav Lopatin/Shutterstock

Study identifies two new Omicron lineages associated with a resurgence in infections in South Africa

by Medical Finance
May 20, 2022
0

In a recent study posted to the medRxiv* preprint server, researchers assessed the emergence and evolution of severe acute respiratory...

Next Post
Study: Real-World Efficacy of Regdanvimab on Clinical Outcomes in Patients with Mild to Moderate COVID-19. Image Credit: plo/Shutterstock

Clinical outcomes of regdanvimab usage in patients with mild to moderate COVID-19

Manipulating carotenoids can improve plant growth, stress tolerance and increase yield

Manipulating carotenoids can improve plant growth, stress tolerance and increase yield

0 0 votes
Article Rating
Subscribe
Login
Notify of
guest
guest
0 Comments
Inline Feedbacks
View all comments

Support

  • Contact
  • Disclaimer
  • Home
  • Privacy Policy
  • Terms And Conditions

Categories

  • Coronavirus
  • Insights From Industry
  • Interviews
  • Mediknowledge
  • News
  • Thought Leaders
  • Whitepapers

More News

  • Osteoporosis stage 3 of 4 upper limb bones 3d rendering Crevis M1 62ee9a3e223b497ca6798e45d894de93 620x480
    Messenger RNA can be used at low doses to regenerate bone without side effects
  • Respiratory 620x480
    Breath tests can help detect traces of SARS-CoV-2 virus
  • Home
  • Privacy Policy
  • Contact
  • Disclaimer
  • Terms And Conditions

© 2022 Medical Finance - Latest Financial and Business News

No Result
View All Result
  • Interviews
  • Mediknowledge
  • News
  • Insights From Industry
  • Coronavirus
  • Thought Leaders
  • Whitepapers
wpDiscuz
0
0
Would love your thoughts, please comment.x
()
x
| Reply